Does Acute Necrotizing Encephalopathy Occur in Familial Patterns?
Yes, acute necrotizing encephalopathy (ANE) definitively occurs in familial patterns with autosomal dominant inheritance, most commonly associated with mutations in the RANBP2 gene. 1
Genetic Basis and Inheritance Pattern
The familial form of ANE follows an autosomal dominant inheritance pattern with identified genetic mutations 1. The RANBP2 gene is implicated in approximately 81% of genetically tested familial cases 2. However, familial ANE can occur even without detectable RANBP2 mutations, suggesting additional genetic susceptibility factors 3.
Key genetic findings include:
- RANBP2 mutations (most common, particularly c.1754C>T and c.5249C>G variants) 4, 5
- Digenic inheritance patterns have been documented, involving both RANBP2 and CPT2 gene variants 5
- Incomplete penetrance occurs, meaning carriers may remain asymptomatic despite having the mutation 4
Clinical Distinction: Sporadic vs Familial ANE
ANE presents in two major forms 6:
Sporadic ANE:
- Isolated, non-recurrent cases
- Primarily triggered by viral infections (influenza, HHV-6, SARS-CoV-2)
- Most commonly reported in young children in Japan and Southeast Asian countries 1
Familial/Recurrent/Genetic ANE (F/R/G ANE):
- Recurrent episodes triggered by infections in genetically susceptible individuals 2
- Median onset age 24 months, with 62% male predominance 2
- Can present with atypical events (infection-triggered encephalopathy without bithalamic involvement) in 13% of patients before a definitive ANE episode 2
Clinical Implications for Recognition
When evaluating a child with suspected ANE, obtain detailed family history specifically asking about:
- Siblings or relatives with unexplained encephalopathy following febrile illnesses
- Family members with recurrent neurological deterioration after infections
- Deaths in childhood following viral infections with rapid neurological decline 4
The presence of multiple affected family members or recurrent episodes in the same patient should prompt genetic testing for RANBP2 mutations 2, 4.
Prognostic Differences
Familial ANE carries distinct prognostic implications:
- Recurrence risk with subsequent infections
- Variable clinical severity even within the same family due to incomplete penetrance 4
- Mortality documented in familial cases, with some siblings dying while others remain asymptomatic despite carrying the mutation 4
Critical Pitfall
Do not dismiss the possibility of familial ANE based on negative RANBP2 testing alone. Recent case reports demonstrate familial clustering without identifiable RANBP2 mutations, indicating other genetic susceptibility factors exist 3. The COVID-19 pandemic has revealed additional familial cases associated with SARS-CoV-2 infection where RANBP2 testing was negative 3.
Vaccination Considerations in Familial Cases
Limited data from 18 patients with documented pre-ANE vaccination history and 5 patients who resumed vaccination post-ANE showed no vaccine-related relapses over median follow-up of 19 months 2. However, prospective studies are needed to establish definitive vaccination safety protocols in genetically susceptible individuals.